Re‐interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation
The Journal of Pathology · 2023
DOI: 10.1002/path.6070 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2023. Verfasst von Paul Aw Edwards. Beteiligte Einrichtung: Department of Pathology, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Breast Cancer Now.
Abstract (Originalsprache)
Much of tumour cell biology and the tumour microenvironment may be normal wound‐healing responses as a consequence of the disruption of tissue structure. This is why tumours resemble wounds, and many features of the tumour microenvironment, such as the epithelial–mesenchymal transition, cancer‐associated fibroblasts, and inflammatory infiltrates, may largely be normal responses to abnormal tissue structure, not an exploitation of wound‐healing biology. © 2023 The Author. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Cambridge, Cambridge, UK.
ORCID-Profile: Paul Aw Edwards
Förderung
- Cancer Research UK
- Breast Cancer Now
Zitieren
APA
Edwards, P. A. (2023). Re‐interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation. The Journal of Pathology. https://doi.org/10.1002/path.6070
Vancouver
Edwards PA. Re‐interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation. The Journal of Pathology. 2023. doi:10.1002/path.6070
BibTeX
@article{Edwards2023,
author = {Edwards, Paul Aw},
title = {Re‐interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation},
journal = {The Journal of Pathology},
year = {2023},
doi = {10.1002/path.6070}
}
EUVIMED